ArticleMayo Clinic proceedings2021
In Reply - Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019.
Zelalem Temesgen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleMayo Clinic proceedings2021
Zelalem Temesgen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.